Biogen’s Aduhelm, the Alzheimer’s drug that has faced resistance from insurers, will now only be available to a small pool of patients.
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to prescribe it yet. Illustration: Jacob ReynoldsPeople with Alzheimer’s disease will be less likely to receive Biogen Inc.’s Aduhelm treatment because of thefor the drug in the face of restricted reimbursement by the U.S. Medicare program and other insurers.
The Cambridge, Mass., company said Tuesday that it is eliminating its “commercial infrastructure” for Aduhelm. It will maintain minimal resources to provide the drug for patients currently on the treatment at no cost.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Change at the top for Biogen after Alzheimer's drug flopsBiogen is looking for a new CEO less than a year after its launch of its Alzheimer’s drug Aduhelm largely fizzled. The company said Tuesday that current CEO Michel Vounatsos will continue to lead the company until his successor is appointed.
Read more »
Biogen CEO Michel Vounatsos to Step Aside After Alzheimer’s Drug StrugglesMichel Vounatsos’s resignation comes as the company attempts to chart a new course following Medicare’s refusal to cover its new Alzheimer’s drug Aduhelm.
Read more »
Spirit will continue to pursue a merger with Frontier instead of JetBlueSpirit says a deal with JetBlue isn’t likely to receive antitrust clearance.
Read more »
Why Women and Girls With Autism Spectrum Disorder Are Less Likely to Get a DiagnosisLearn why women and girls experience autism differently, and why diagnosis is so important.
Read more »
A New Way to Measure What Actually Matters to PatientsThe same symptoms don't bother all patients equally, so why should they have to use the same measures? Here's what to try instead, writes bhaviorscientst
Read more »
David Birney, 'St. Elsewhere' Actor, Dead at 83'St. Elsewhere' and 'Bridget Loves Bernie' star David Birney has died at 83.
Read more »